Trade Summary

3 days ago, Raben David, serving as Chief Medical Officer at Bicara Therapeutics Inc. (BCAX), sold 16,500 shares at $18.52 per share, for a total transaction value of $305,610.00. Following this transaction, Raben David now holds 55,286 shares of BCAX.

This sale represents a 23.00% decrease in Raben David's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.